Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity


Creative Commons License

Gunay M. , ÇELİK G., Gunay B. O. , AKTAŞ A., KARATEKİN G., Ovali F.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, vol.78, no.5, pp.300-304, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 78 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.5935/0004-2749.20150079
  • Title of Journal : ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Page Numbers: pp.300-304

Abstract

Purpose: To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).